Condition
GORD
Total Trials
5
Recruiting
0
Active
1
Completed
1
Success Rate
50.0%-37% vs avg
Key Insights
Highlights
Success Rate
50% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 65/100
Termination Rate
20.0%
1 terminated out of 5 trials
Success Rate
50.0%
-36.5% vs benchmark
Late-Stage Pipeline
40%
2 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
50% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (1)
P 3 (1)
P 4 (1)
Trial Status
Unknown2
Terminated1
Completed1
Active Not Recruiting1
Trial Success Rate
50.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT03835663Active Not RecruitingPrimary
The Bacterial Composition of the Stomach in Reflux Disease
NCT04293107Unknown
Gastro-oesophageal Reflux and NeuroDisability (Cerebral Palsy) in CHILDren
NCT00261339Phase 4Completed
Determination of a Questionnaire After Treatment With Pantoprazole at Full Dose and Half Dose in Adult Patients With Symptoms of Acid Reflux (Gastroesophageal Reflux Disease) (BY1023/UK-506)
NCT00604942Not ApplicableTerminated
vMII for Measurement of Oesophageal Bolus Transport and Reflux
NCT00161096Phase 3Unknown
On-Demand Use of Pantoprazole: Determinants for Chronic Use of Acid Suppressive Medication
Showing all 5 trials